Harvest Receives CE for its Autologous Point of Care Bone Marrow System Which Concentrates 200 Million Mono-Nucelated Cells Including Stem Cells From a Small 60 CC Sample
PLYMOUTH, Mass., Sept. 21 /PRNewswire/ -- Harvest(R) Technologies
Corporation, announced today that it had received authorization to mark its
autologous point of care Bone Marrow Concentration Systems with the CE Mark
and is seeking distribution within the European Union. The autologous point of
care bone marrow concentration kit is a total system that includes all
necessary components to rapidly produce a concentrated quantity of mono-
nucleated cells, containing stem cells, from a small 60cc sample of bone
marrow. The mono-nucleated cells are concentrated seven fold which produces a
yield of 200 million cells. The concentrated bone marrow maybe co-
administrated with Harvest's autologous thrombin product currently being
marketed in Europe. Both products can be produced simultaneously within the
SmartPReP System.
The Harvest Bone Marrow Concentration System is a completely automated
approach that concentrates mono-nucleated cells (200 million) from a small
sample (60cc) of the patient's bone marrow within 15 minutes. Since the bone
marrow concentration is autologous and is concentrated at point of care a
physician is free to use the product within his practice of medicine. The most
obvious applications are bone grafting for bone voids and defects eliminating
the need for an autologous bone harvest procedures. Concentrated mesenchymal
stem cells have demonstrated positive outcomes within the scientific
literature for treating Osteonecrosis, Osteoarthritis and for Spinal Disc
Regeneration. Harvest is expecting that its new, easy to use System for
concentrating these important cells will greatly expand their use and offer
the physician an important tool for the treatment of these debilitating
conditions.
Harvest GMBH located in Munich Germany is currently introducing the
Harvest Bone Marrow Concentration Systems to its key customers. Harvest GMBH
is planning to have European Distribution in place during the forth quarter of
this year.
CONTACT:
Gary Tureski,
President & Co-founder
Harvest Technologies Corp.
508-732-7500
gtureski@harvesttech.com
SOURCE Harvest Technologies Corporation
More by this Source
Harvest Technologies Corporation Files Amended Patent Infringement Complaint against ThermoGenesis Corporation and Celling Technologies LLC
Feb 20, 2013, 13:37 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.




